Compliance Rate

Compliance Rate 48.0%
Compliant submissions 48
Incompliant submissions 52
Total trials 100

Your Clinical Trials

Showing 539450 of 542236 entries
View as:

sCD163 & CD19 as Candidate Biomarkers in CIDP and MMN

Phase: N/A Priority: Normal
NCT ID: NCT02271724 Org: User:
Start: 09/30/15 End: 11/30/16 Due: 11/30/17

OLE Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001

Phase: N/A Priority: Normal
NCT ID: NCT04575259 Org: User:
Start: 10/10/19 End: 06/30/22 Due: 06/30/23

Kinetics of Etheric Oils, Smart Textiles vs. Ointment

Phase: N/A Priority: Normal
NCT ID: NCT00299559 Org: User:
Start: 03/31/06 End: 08/31/06 Due: 08/31/07

Study to Assess Relative Bioavailability and Safety of AZD5718 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04734275 Org: User:
Start: 02/01/21 End: 03/25/21 Due: 03/25/22

Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid Response

Phase: N/A Priority: Normal
NCT ID: NCT04351126 Org: User:
Start: 04/01/19 End: 02/29/20 Due: 02/28/21

Safety Evaluation of Use Sodic Enoxaparin

Phase: N/A Priority: Normal
NCT ID: NCT00673426 Org: User:
Start: 01/31/08 End: 04/30/08 Due: 04/30/09

To Demonstrate the Effect of Food on the Bioavailability of Glipizide

Phase: N/A Priority: Normal
NCT ID: NCT00947024 Org: User:
Start: 11/30/93 End: 11/30/93 Due: 11/30/94

Evaluation of the Effects of Semen Incubation With ANDROSITOL®DGN on Sperm Motility and Mitochondrial Membrane Potential

Phase: N/A Priority: Normal
NCT ID: NCT04291495 Org: User:
Start: 10/23/18 End: 10/31/20 Due: 10/31/21

Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced HCC

Phase: N/A Priority: Normal
NCT ID: NCT01897610 Org: User:
Start: 12/31/13 End: 07/04/17 Due: 07/04/18

Effect of Social Accountability on Improving Service Delivery and Outcomes in the Public Sector in Uttar Pradesh, India

Phase: N/A Priority: Normal
NCT ID: NCT02879708 Org: User:
Start: 04/30/15 End: 02/28/21 Due: 02/28/22

A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)

Phase: N/A Priority: Normal
NCT ID: NCT03114657 Org: User:
Start: 03/29/17 End: 06/11/19 Due: 06/11/20

Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNA-level-relapse and Clinical-relapse Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT05502991 Org: User:
Start: 12/11/22 End: 12/31/27 Due: 12/31/28

Effects of Lansoprazole on Bone Turnover Markers

Phase: N/A Priority: Normal
NCT ID: NCT04814316 Org: User:
Start: 12/02/19 End: 07/01/21 Due: 07/01/22

Spinal Versus Local Anesthesia for Hernia Repair

Phase: N/A Priority: Normal
NCT ID: NCT05136534 Org: User:
Start: 01/10/19 End: 02/12/20 Due: 02/12/21

Safety and Efficacy of Anti-CD47, ALX148 in Combination with Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05467670 Org: User:
Start: 03/30/23 End: 12/31/31 Due: 12/31/32

Deep Brain Stimulation (DBS) for the Treatment of Refractory Alcohol Use Disorder (AUD): Pilot Trial

Phase: N/A Priority: Normal
NCT ID: NCT03660124 Org: User:
Start: 05/25/18 End: 12/25/24 Due: 12/25/25

SubQStim: A Post-market Study of Subcutaneous Nerve Stimulation in Failed Back Surgery Syndrome (FBSS) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01711619 Org: User:
Start: 11/30/12 End: 02/29/16 Due: 02/28/17

Effects of Chemoradiation and Surgery on Cardiopulmonary Fitness and Tumor Neoplastic Phenotype in Gastrointestinal Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT02235441 Org: User:
Start: 11/30/14 End: 04/05/16 Due: 04/05/17

Comparison of High Flow Nasal Cannula and Standard Face Mask Oxygen Therapy in Children With Bronchiolitis

Phase: N/A Priority: Normal
NCT ID: NCT04245202 Org: User:
Start: 03/14/17 End: 03/10/20 Due: 03/10/21

Administration of Dexmedetomidine Guided by Entropy/SPI Reduce

Phase: N/A Priority: Normal
NCT ID: NCT02818621 Org: User:
Start: 10/31/14 End: 10/31/17 Due: 10/31/18

Alexithymia and Attachment Style in Patients With Somatic Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT05666921 Org: User:
Start: 06/15/21 End: 11/01/24 Due: 11/01/25

Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00073502 Org: User:
Start: 10/31/03 End: 10/31/03 Due: 10/31/04

Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00334802 Org: User:
Start: 06/30/06 End: 03/31/10 Due: 03/31/11

Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04060459 Org: User:
Start: 10/01/18 End: 10/31/22 Due: 10/31/23

X-82 to Treat Age-related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT02348359 Org: User:
Start: 03/16/15 End: 01/12/18 Due: 01/12/19